Ep. 558: Supplying COVID-19 Therapeutics
As urgent requests for convalescent plasma, Remdesivir and Tocilizumab increase, Ruturaj Gowaikar and Shambhavi Naik discuss the application of these therapeutics and the unnecessary shortage caused by poor public engagement over their utility.
If these policy conversations interest you, consider applying for Takshashila's Graduate Certificate in Public Policy. Applications for the monsoon cohort close soon. You can check out our courses here - www.takshashila.org.in/courses
You can follow Ruturaj Gowaikar on Twitter: @RuturajGowaikar
You can follow Shambhavi Naik on Twitter: @TheNaikMic